Amendment_2_NIHAI2015040.pdf
PDF 19 KB Posted
- Attached to
- Staged Vaccine Development Federal contract opportunity
- Solicitation number
- NIAID-DAIDS-NIHAI2015040
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Amendment_3_NIHAI2015040.pdf | ||
| Amendment_1_NIHAI2015040.pdf | ||
| NIHAI2015040_with_attachments.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Pre-Sol AMENDMENT #1, BAA NIAID-DAIDS-NIHAI2015040
Amendment No. 2 Pre-Solicitation Notice
BAA-NIAID-DAIDS-NIHAI2015040
“Staged Vaccine Development”
Solicitation Number:
Amendment Number:
Amendment Issue Date:
RFP-NIAID-DAIDS-NIHAI2015040
Two (2)
July 9, 2015
Response Date:
Thursday, August 20, 2015 at 3:00 PM, Local Time (Unchanged)
Issued By: Michelle L. Scala Contracting Officer
OA/DEA/NIAID/NIH/DHHS
5601 Fishers Lane, Room 3D10 Bethesda, Maryland 20892-9821
Points of Contact: PRIMARY:
Callie Durand, Contract Specialist durandca@niaid.nih.gov Phone: 240-669-5155
SECONDARY:
Michelle L. Scala, Contracting Officer mscala@niaid.nih.gov Phone: 240-669-5156
The purpose of this amendment is to answer a question from potential offeror regarding the solicitation.
Question from Potential Offeror:
Question 2:
If need bivalent mosaic MVAs, I.e. MVA.tHIVconsv3 and MVA.tHIVconsv4 is needed, do two Stage Vaccine Development applications need to be written?
Response to Question 2:
Since this is a MVA vaccine platform with two different inserts, manufacturing of both the constructs could be included in one proposal as long as they are related components of same design and manufacture process.
mailto:durandca@niaid.nih.gov mailto:anhughes@niaid.nih.gov
File details come from the government source that posted it. Updated .